Contamination Control

Published: 14-Jan-2011

29 - 31 March 2011

Prague, Czech Republic

Course designed to cover all important aspects of controlling microbiological contamination. It ranges from sources of contamination to validation of cleaning and disinfection processes and training of operators. A focus will be on those problems that occur frequently in pharmaceutical production; possible solutions to these challenges will be discussed.

This course is aimed at associates from life science industries who are involved in:

  • Microbial monitoring
  • Implementation of hygiene programmes
  • Selection and qualification of disinfectants
  • Handling of microbial deviations
  • Training of operators for monitoring and sanitising measures

Special offer for Cleanroom Technology visitors: Register for the course with the code ct2011 and you will receive a €100 rebate on the registration fee. Please make sure to mention the code in the Comment field.

Organiser: European Compliance Academy/Concept Heidelberg

Trending Articles

  1. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  2. Clinical Pharmacy Congress 10-11 May 2024 | Conference | London, UK
  3. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  4. Cleanroom Conference Singapore 2023 5-6 December 2023 | Conference and Exhibition | Downtown, Singapore
  5. Cleanroom Technology Conference UK 22–23 May 2024 | Conference and Exhibition | Birmingham, UK

You may also like

Training & Education

Pharmaceutical training specialist Concept Heidelberg expands

Concept Heidelberg has finished work on its new building and now uses almost 2,000 square meters of office space.
Regulatory

The roadmap for supplier qualification

Wolfgang Schmitt of Concept Heidelberg explains the process required to minimise risks arising from outsourcing and ensure a good and steady relationship with suppliers
Regulatory

Deviations and CAPAs are hot topics in GMP inspections

GMP experts at the ECA Academy comment on a warning letter issued to Glenmark by the FDA
Design & Build

Editor’s comment: More than buzz words

It’s time to go beyond the gimmick as only companies aligned with the forefront of technology will capitalise on the advantages they bring
Regulatory

Medicinal cannabis: What it takes to be GMP-ready

The legalisation of cannabis for medicinal purposes pushes producers to supply chemists, physicians and patients with the newly approved drug in accordance with good manufacturing and distribution practices, as Dr Andrea Kühn-Hebecker explains
Regulatory

Procurement and GMP: A conflict in objectives?

A deeper understanding of the unique requirements and the underlying GMP guidelines is essential for purchasing in the pharmaceutical industry. Axel H. Schroeder of Concept Heidelberg, explains
Regulatory

Bioanalytical strategy: Authorities’ expectations to consider

Dr Markus Fido, analytical characterisation expert and VelaLabs co-founder, looks at the product lifecycle of biopharmaceuticals to describe the methods manufacturers should use to ensure required safety and quality under Directive 2001/83/EC
Subscribe now